AI drug discovery Archives -

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research

The future of AI drug discovery & development in immunology and GPCR research

https://pharmaphorum.com/digital/the-future-of-ai-drug-discovery-development-in-immunology-and-gpcr-research/

Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise

https://pharmaphorum.com/news/diving-deeper-into-ai-discovery-sanofi-signs-5-drug-deal-with-atomwise/

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential

AI tissue analysis enables rapid discovery of drug candidates

https://pharmaphorum.com/digital/ai-tissue-analysis-enables-rapid-discovery-of-drug-candidates/

Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule

Insilico’s AI-discovered, AI-designed IPF drug enters Phase 1 trials

https://pharmaphorum.com/news/insilicos-ai-discovered-ai-designed-ipf-drug-enters-phase-1-trials/

AI drug discovery